Merck (MRK) Ends '12 on High Note Despite SINGULAIR Weakness; '13 EPS Guidance Muted
Tweet Send to a Friend
Shares of Merck (NYSE: MRK) ticked lower early on Friday after the drug maker reported Q4 results. While the EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
